Heart International

Heart International is an open access cardiology journal that has been published by Touch Medical Media from Reading, England since 2018, and its 2025 Journal Impact Factor is 2.4.《国际心脏》是一份开放获取的心脏病学期刊，2018 年起由英格兰雷丁的 Touch Medical Media 出版，2025 年期刊影响因子为 2.4。

Two issues appear each year, and every article is addressed by a digital object identifier built from the year, volume and issue, which is how a paper published between issues is cited until the number closes.刊物每年出两期，每篇文章都带一个由年、卷、期拼成的数字对象标识，某一期尚未收齐时上线的论文就靠它被引用。

Scope

• The subject is clinical cardiology as it is practised, with an emphasis on catheter-based treatment, and the readership is made up of cardiologists who treat patients rather than of basic scientists.刊物处理的是临床实践中的心脏病学，重心放在经导管治疗上，读者是诊治病人的心内科医生，而非基础研究者。
• Coronary intervention takes the largest share, from acute coronary syndromes and stent selection to bifurcation technique and the management of calcified lesions that resist balloon expansion.冠状动脉介入占去最大篇幅，从急性冠脉综合征与支架选择，到分叉病变技术，以及球囊扩不开的钙化病变如何处理。
• Structural heart disease has grown into a field of its own, covering transcatheter aortic valve replacement, mitral repair, left atrial appendage closure and the imaging that decides whether a patient is a candidate at all.结构性心脏病已自成一域，涵盖经导管主动脉瓣置换、二尖瓣修复、左心耳封堵，以及决定病人到底能不能做的那套影像评估。
• Peripheral and endovascular work is treated as core rather than incidental, taking in critical limb ischaemia, limb salvage, carotid stenting and the below-the-knee vessels that decide whether a foot is saved.外周与血管内介入被当作核心内容而非附庸，涵盖危重肢体缺血、保肢、颈动脉支架，以及决定一只脚能否保住的膝下血管。
• Electrophysiology appears through ablation strategy, device therapy and the management of atrial fibrillation, areas where the interventional and the medical sides of cardiology meet.电生理通过消融策略、器械治疗与房颤管理进入刊物，这些领域正是心脏病学中介入与药物治疗交汇之处。
• Heart failure is handled across the devices and drugs that keep a patient out of hospital, including remote monitoring of pulmonary pressure and the titration schedules that decide whether a device earns its cost.心力衰竭围绕让病人不住院的那批器械与药物展开，也包括肺动脉压远程监测，以及决定一台器械是否值回成本的调药方案。
• Imaging runs through nearly every section, since echocardiography, computed tomography and magnetic resonance now sit at the front of most treatment decisions rather than at the end as confirmation.影像几乎贯穿每一栏，超声、计算机断层与磁共振如今多处在治疗决策的前端，而不再只在末尾充当确认。
• Prevention and risk factor control take in lipids, hypertension, diabetes and smoking cessation, with attention to how targets set in guidelines survive contact with a busy clinic.预防与危险因素控制涵盖血脂、血压、糖尿病与戒烟，也关注指南里定下的目标值回到繁忙门诊之后还能剩下多少。
• Case reports are welcome when the case teaches something a reader could not get from a trial, such as an unusual complication of a common device or a presentation that mimics something else.病例报告只要能让读者学到试验里学不到的东西就受欢迎，比如常见器械的不常见并发症，或某种表现把别的病模仿得很像。
• Technical notes describe a step, a catheter choice or a bailout manoeuvre in enough detail that another operator could repeat it in a similar anatomy.技术说明把一个步骤、一种导管选择或一次救急手法写到另一位术者能在相似解剖条件下照做的程度。
• Reviews are written for the clinician deciding on Monday morning, so a synthesis is judged on whether it resolves a practical question rather than on whether it lists every paper in the field.综述写给周一早上就要作决定的那类医生，因此判断一篇综述好坏，看它有没有解决一个实际问题，而不是看它有没有把领域里的论文列全。
• Authorship is international by design, and papers from centres in Asia, Latin America and the Middle East appear alongside those from established European and North American institutions.作者来源刻意保持国际性，来自亚洲、拉丁美洲与中东中心的论文，与欧洲和北美老牌机构的论文并列刊出。
• Device evaluation sits inside the clinical remit, from first-in-human reports to registry data on how a valve or a stent performs once it leaves the trial population.器械评价包含在临床范围之内，从首次人体试验报告，到瓣膜或支架离开试验人群之后在登记数据里的表现。

History

• The journal began in 2005 in Pavia, Italy, issued by PagePress on behalf of Wichtig Editore, at a moment when Italian medical publishing was experimenting with author-pays open access.刊物 2005 年在意大利帕维亚创刊，由 PagePress 代表 Wichtig Editore 发行，当时意大利的医学出版正在试水作者付费的开放获取。
• That origin explains the open access footing. The Directory of Open Access Journals dates the journal's open access status to 2006, one year after the first volume, and it has never sat behind a subscription.这一出身解释了它的开放获取底色。开放获取期刊目录把本刊的开放获取状态记为 2006 年，即创刊次年，此后它从未落进订阅墙。
• PubMed began indexing at volume 2 in 2006 and the journal has been in PubMed Central since, which gave early papers a permanence that many society titles of the period lacked.PubMed 从 2006 年第 2 卷起收录，刊物此后一直在 PubMed Central 之中，早年论文因此获得了同期不少学会刊物没有的长期可及性。
• The Italian volumes came out irregularly. Some years produced two or three issues, some produced one, and volume 3 carried papers dated across 2007 to 2009.意大利时期的各卷出得不规律。有的年份两三期，有的年份只有一期，第 3 卷的文章年份从 2007 年一直跨到 2009 年。
• Volume 12 closed in 2017 and marked the end of the PagePress arrangement, a run of thirteen years that had built a small but international body of cardiology papers.第 12 卷在 2017 年收尾，也标志着 PagePress 时期的结束，十三年的积累为刊物攒下一批规模不大但来源广泛的论文。
• Touch Medical Media took the title over in 2018 and moved it to Reading, England, an address that the National Library of Medicine now records as the current imprint.Touch Medical Media 于 2018 年接手，把刊物迁到英格兰雷丁，美国国家医学图书馆如今把这个地址记为现行出版地。
• No volume was dated 2018. Volume 13 arrived in 2019 with two issues, and every volume since has carried exactly two, which makes the twice-yearly rhythm a settled arrangement rather than an ambition.2018 年没有出卷。第 13 卷到 2019 年才出现，编了两期，此后每一卷都正好两期，一年两度于是成为定局而不是打算。
• Identifiers carry the year and the volume together, so a 2024 paper in volume 18 issue 2 is registered as HI.2024.18.2 under the 10.17925 prefix, and the pattern has been stable since the transfer.文章标识把年份与卷号写在一起，2024 年第 18 卷第 2 期的论文登记为 10.17925 前缀下的 HI.2024.18.2，这一写法自交接以来没有变过。
• The impact factor has moved within a narrow band, 1.9 in 2023, 2.3 in 2024 and 2.4 in 2025, against a five-year figure of 2.0.影响因子一直在一个窄带里移动，2023 年 1.9，2024 年 2.3，2025 年 2.4，五年影响因子为 2.0。
• Clarivate places it in the emerging sources edition of the cardiac and cardiovascular systems category at 117 of 237 titles, a second-quartile position reached without a science citation index expanded listing.科睿唯安把它放在心血管系统类目的新兴来源版，237 种中第 117 位，这个第二四分位的位置是在尚未进入科学引文索引扩展版的情况下拿到的。
• Output is small, twelve citable items in the 2025 window, which suits a journal built on review and case material. Total citations stand at 287 with a cited half-life of 5.4 years.发文量很小，2025 年被引窗口内只有 12 篇可被引文献，这与一份以综述和病例材料为主的刊物相称。总被引 287 次，被引半衰期 5.4 年。
• Scopus puts the CiteScore at 0.9 for 2024, a figure that reflects the review-heavy mix, since reviews gather citations more slowly than primary research in a fast-moving procedural field.Scopus 给 2024 年的 CiteScore 是 0.9，这个数字与综述偏多的构成有关，在一个变化很快的介入领域里，综述聚引的速度慢于原始研究。
• Nothing about the title has changed. It carries the older print number 1826-1868 from the Pavia years and the electronic 2036-2579 that now identifies every article online.刊名从未改动。它保留着帕维亚时期的旧印本刊号 1826-1868，以及如今标识每篇线上文章的电子刊号 2036-2579。
• Gold open access accounts for 79.41 percent of recent papers, and the share of the list that is free at the point of reading is the publisher's model rather than an option offered alongside a subscription.近年论文有 79.41% 属金色开放获取，而且这份刊物的内容在阅读端免费，是出版方的模式，而不是订阅之外另设的选项。

Editors

• Magdi El-Omar, a consultant interventional cardiologist at the Manchester Heart Centre and honorary senior lecturer at the University of Manchester, is one of two editors-in-chief.Magdi El-Omar 是两位主编之一，他是曼彻斯特心脏中心的介入心脏病学顾问医生，也是曼彻斯特大学的名誉高级讲师。
• Rajesh Davé holds the other editorship from Camp Hill, Pennsylvania, where he chairs the cardiology department at Holy Spirit Cardiovascular Institute and founded the C3 interventional congress.Rajesh Davé 在宾夕法尼亚州坎普希尔担任另一位主编，他是 Holy Spirit 心血管研究所心内科主任，也是 C3 介入大会的创办人。
• Nine editorial board members divide the subspecialties, among them Gustavo Samaja in Buenos Aires, Shouvik Haldar at Royal Brompton in London and Ashok Seth at Fortis Escorts in New Delhi.九位编委分担各亚专科，其中包括布宜诺斯艾利斯的 Gustavo Samaja、伦敦皇家布朗普顿医院的 Shouvik Haldar，以及新德里富通护卫心脏研究所的 Ashok Seth。
• Structural and peripheral work is represented by Bryan Kluck in Camp Hill, Barry Uretsky at the University of Arkansas and Nilesh Balar, who chairs surgery at St Michael's Medical Center in Newark.结构与外周介入一侧由坎普希尔的 Bryan Kluck、阿肯色大学医学院的 Barry Uretsky，以及新泽西州纽瓦克圣迈克尔医学中心外科主任 Nilesh Balar 代表。
• Pathology and device science come in through Aloke Finn at the CVPath Institute in Gaithersburg, whose work on stent healing sits close to the questions the journal's interventional papers raise.病理与器械科学由盖瑟斯堡 CVPath 研究所的 Aloke Finn 带入，他对支架愈合的研究与刊物介入类论文提出的问题正好相邻。
• An advisory board of about a dozen sits above the day-to-day handling, with Sheldon Goldberg at Penn, Jose Luis Merino in Madrid, Prakash Deedwania at UCSF and Mohamed Sobhy in Alexandria among its members.一个约十余人的顾问委员会位于日常编务之上，成员包括宾夕法尼亚大学的 Sheldon Goldberg、马德里的 Jose Luis Merino、加州大学旧金山分校的 Prakash Deedwania，以及亚历山大的 Mohamed Sobhy。
• Review is double anonymous, as the journal's listing in the Directory of Open Access Journals records, so neither author nor referee learns the other's identity during assessment.评审采用双盲方式，刊物的开放获取期刊目录条目对此有记录，作者与审稿人在评审期间都不知道对方是谁。
• Submissions enter through the publisher's Editorial Manager site, and the editorial office sits with the publisher in Reading rather than with a society or a hospital department.稿件从出版方的 Editorial Manager 站点进入，编辑部与出版方同在雷丁办公，而不挂在某个学会或医院科室之下。
• A case report has to carry written consent from the patient, and identifying detail is removed before review, a rule that matters in single-centre reports from small hospitals.病例报告必须附病人书面同意，可辨认身份的细节在送审前即行删除，这条规矩对小医院单中心报告尤其要紧。
• A technical note is judged on repeatability. The editors want the device sizes, the access route and the failure modes stated, not a narrative of how the case went well.技术说明按可重复性评判。编辑要的是器械规格、入路与失效情形，而不是一篇病例如何顺利完成的叙述。
• Interventional cardiology runs on industry support, so disclosure is enforced at submission, and a paper reporting a device is expected to say who funded the work and what the authors hold.介入心脏病学高度依赖产业支持，因此利益冲突在投稿时就要申报，报告某种器械的论文须写明谁出资、作者持有什么。
• Every accepted article is published with its DOI at once, so the editorial record reflects decisions made for the issue rather than a queue held until a number is assembled.每篇录用文章都立刻带 DOI 上线，编辑决策因此服务于当期编排，而不是攒着等一期凑齐再放。